Similar articles

• [The results of using high-dose methotrexate in treating osteogenic sarcoma].

  Perevodchikova NI, Eremina LA, Manziuk LV, Siniukov PA, Fedenko AN, Singin AS, Moldovanova LK. Perevodchikova NI, et al. Vopr Onkol. 1990;36(6):667-71. Vopr Onkol. 1990. PMID: 2378085 Russian.
• Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?

  Bacci G, Picci P, Gherlinzoni F, Van Horn JR, Orlandi M, Normand AR, Manfrini M, Pignatti G, Campanacci M. Bacci G, et al. Chemioterapia. 1986 Apr;5(2):140-3. Chemioterapia. 1986. PMID: 3458546
• Osteogenic sarcoma studies by the Cancer and Leukemia Group B.

  Cortes EP, Holland JF, Glidewell O. Cortes EP, et al. Natl Cancer Inst Monogr. 1981 Apr;(56):207-9. Natl Cancer Inst Monogr. 1981. PMID: 7029290 Clinical Trial. No abstract available.
• [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].

  Delépine N, Alkallaf S, Cornille H, Markowska B, Delépine G. Delépine N, et al. Ann Med Interne (Paris). 2003 Feb;154(1):12-24. Ann Med Interne (Paris). 2003. PMID: 12746655 Review. French.
• Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.

  Miser JS, Pritchard DJ, Rock MG, Shives TC, Gilchrist GS, Smithson WA, Arndt CA, Edmonson JH, Schaid DJ. Miser JS, et al. Cancer Treat Res. 1993;62:333-8. Cancer Treat Res. 1993. PMID: 8096748 Review. No abstract available.